You just read:

Merck to Present Data on MAVENCLAD™ (Cladribine Tablets) and Rebif® (interferon beta-1a) in Patients with Relapsing MS at EAN Congress 2017

News provided by

Merck

24 Jun, 2017, 18:17 BST